Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
14 studies found for:    "alport syndrome"
Show Display Options
Rank Status Study
1 Recruiting Alport Syndrome Treatments and Outcomes Registry
Condition: Alport Syndrome
Intervention:
2 Recruiting A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
Condition: Alport Syndrome
Interventions: Drug: Placebo Oral Capsule;   Drug: Bardoxolone Methyl
3 Active, not recruiting Multi-center Controlled Clinical Trials in Alport Syndrome-A Feasibility Study
Condition: Alport Syndrome
Intervention:
4 Completed A Prospective Study of Microalbuminuria in Untreated Boys With Alport Syndrome
Condition: Alport Syndrome
Intervention:
5 Completed Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport Syndrome
Condition: Alport Syndrome
Interventions: Drug: ACE I, ATA II and Statins;   Drug: Benazepril, Valsartan and Fluvastatin
6 Active, not recruiting Study of Weekly RG-012 Injections in Patients With Alport Syndrome
Condition: Alport Syndrome
Interventions: Drug: RG-012;   Drug: Placebo
7 Recruiting ATHENA: Natural History of Disease Study in Alport Syndrome Patients
Condition: Alport Syndrome Patients With eGFR Between 45-90 ml/Min/1.73 m2
Intervention:
8 Terminated Human Urine Sample Collection for Alport Nephropathy Biomarker Studies
Condition: Alport Syndrome
Intervention:
9 Completed Urinary Biomarkers of the Progression of Alport Kidney Disease
Condition: Alport Syndrome
Intervention:
10 Recruiting Urine, DNA and Clinical Information Collection From Patients With Alport Nephropathy.
Condition: Alport Nephropathy
Intervention:
11 Recruiting European Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome
Conditions: Alport Syndrome;   Hereditary Kidney Disease;   Pediatric Kidney Disease;   Thin Basement Membrane Disease;   Familial Benign Hematuria
Interventions: Drug: ACE-inhibitor;   Drug: AT1-inhibitor;   Drug: HMG-Coenzyme inhibitor (statin);   Drug: Spironolactone;   Drug: Paricalcitol
12 Recruiting Biomarker for Patient With Alport Disease or Highly Suspected for Alport Disease
Conditions: Nephritis, Hereditary;   Alport Syndrome;   Alport Syndrome, Autosomal Dominant;   Alport Syndrome, Autosomal Recessive;   Hematuria-Nephropathy-Deafness Syndrome
Intervention:
13 Recruiting Efficacy and Safety Study to Delay Renal Failure in Children With Alport Syndrome
Condition: Renal Insufficiency, Chronic
Interventions: Drug: Ramipril;   Drug: placebo to ramipril
14 Completed Enalapril in Collagen Type 4 Nephropathy
Condition: Collagen Type-4 Nephropathies
Intervention:

Study has passed its completion date and status has not been verified in more than two years.